[
    [
        {
            "time": "2018-11-27",
            "original_text": "Medicine or vice? Socially screened funds struggle to define cannabis industry",
            "features": {
                "keywords": [
                    "cannabis",
                    "industry",
                    "socially screened",
                    "struggle"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 4,
                "Duration": 9,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-11-27",
            "original_text": "The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris",
            "features": {
                "keywords": [
                    "JPMorgan",
                    "Procter & Gamble",
                    "UnitedHealth",
                    "McDonald's",
                    "Philip Morris"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "consumer goods",
                    "healthcare",
                    "food service"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 3,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-11-27",
            "original_text": "Validea Joel Greenblatt Strategy Daily Upgrade Report - 11/27/2018",
            "features": {
                "keywords": [
                    "Joel Greenblatt",
                    "strategy",
                    "upgrade",
                    "report"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 3,
                "Impact": 2,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]